During the past decade, Nishi Kumamoto Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nishi Kumamoto Hospital" are "Healthy Adult Participants" (1 trials), "Japanese Healthy Adult Male Participants" (1 trials) and "Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)" (1 trials). Many other conditions were trialed in "Nishi Kumamoto Hospital" in a lesser frequency.

Most popular intervention types in "Nishi Kumamoto Hospital" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "TAK-019" (1 trials), "TAK-536" (1 trials) and "Vortioxetine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nishi Kumamoto Hospital" are 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Nishi Kumamoto Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Nishi Kumamoto Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nishi Kumamoto Hospital, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".